SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-23-065389
Filing Date
2023-03-09
Accepted
2023-03-09 08:34:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d411053dposam.htm POS AM 36097
  Complete submission text file 0001193125-23-065389.txt   37231
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-254884 | Film No.: 23718299
SIC: 2834 Pharmaceutical Preparations